Artes Medical, which has developed an injectable aesthetic treatment for the permanent correction of wrinkles, priced 4.6 million shares at $6, the low end of its revised range. Cowen & Company and Lazard managed the deal. The stock is expected to trade on...read more
Artes Medical, which has developed an injectable aesthetic treatment for the permanent correction of wrinkles, lowered the range for its IPO on Tuesday. The company now plans to offer 4.6 million shares at a range of $6-$8, as opposed to the originally...read more
Artes Medical, a medical technology firm developing injectable aesthetic products for the dermatology and plastic surgery markets, set the terms for its IPO on Monday. The San Diego-based company plans to offer 4.6 million shares at a range of $12-$14, giving...read more
Artes Medical, which is a medical technology firm developing injectable aesthetic products for the dermatology and plastic surgery markets, filed for an IPO with the SEC on Friday. The company has several products in development but has yet to generate sales. ...read more
Artes Medical prices at $6
Artes Medical, which has developed an injectable aesthetic treatment for the permanent correction of wrinkles, priced 4.6 million shares at $6, the low end of its revised range. Cowen & Company and Lazard managed the deal. The stock is expected to trade on...read more
Artes Medical lowers range
Artes Medical, which has developed an injectable aesthetic treatment for the permanent correction of wrinkles, lowered the range for its IPO on Tuesday. The company now plans to offer 4.6 million shares at a range of $6-$8, as opposed to the originally...read more
Biotech Artes Medical sets terms
Artes Medical, a medical technology firm developing injectable aesthetic products for the dermatology and plastic surgery markets, set the terms for its IPO on Monday. The San Diego-based company plans to offer 4.6 million shares at a range of $12-$14, giving...read more
Medical technology firm Artes Medical files to go public
Artes Medical, which is a medical technology firm developing injectable aesthetic products for the dermatology and plastic surgery markets, filed for an IPO with the SEC on Friday. The company has several products in development but has yet to generate sales. ...read more